Xingbao International Co Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xingbao International Co Ltd with three other
drug stores in Asia:
Ibl Healthcare Limited
sales of 931.98 million Pakistan Rupees [US$8.89 million]
Immuno-Biological Laboratories Company Limited
(729.03 million Japanese Yen [US$6.47 million]
of which 69%
was Diagnosis & Reagent), and
U-Home Group Holdings Ltd
based in Hong Kong
(76.00 million Hong Kong Dollars [US$9.79 million]
of which 66%
was Trading Pharmaceutical & Health Care Pro).
Xingbao International Co Ltd reported sales of 244.93 million Taiwanese Dollars (US$8.06 million)
December of 2015.
decrease of 18.3%
versus 2014, when the company's sales were 299.67 million Taiwanese Dollars.